Stockscreener 앱 받기
6.655
1.84%
-0.125
전일 마감가:
$6.78
열려 있는:
$6.78
하루 거래량:
208.27K
Relative Volume:
0.11
시가총액:
$2.46B
수익:
$9.47B
순이익/손실:
$-178.00M
주가수익비율:
-13.86
EPS:
-0.48
순현금흐름:
$1.01B
1주 성능:
+5.47%
1개월 성능:
+4.31%
6개월 성능:
-13.80%
1년 성능:
+13.18%
1일 변동 폭
$6.63
$6.84
1주일 범위
$6.29
$6.895
52주 변동 폭
$4.25
$9.85
Bausch Health Companies Inc Stock (BHC) Company Profile
명칭
Bausch Health Companies Inc
전화
514-744-6792
주소
2150 ST. ELZEAR BLVD. WEST, QUEBEC, QC
BHC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BHC
Bausch Health Companies Inc
|
6.655 | 2.46B | 9.47B | -178.00M | 1.01B | -0.48 |
|
ZTS
Zoetis Inc
|
151.94 | 68.32B | 9.29B | 2.52B | 2.28B | 5.57 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.44 | 46.55B | 30.08B | 710.16M | 4.45B | 0.2182 |
|
HLN
Haleon Plc Adr
|
9.805 | 43.80B | 14.35B | 1.85B | 0 | 0.4023 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.43 | 19.01B | 16.54B | -1.64B | 749.00M | -1.45 |
|
UTHR
United Therapeutics Corp
|
305.58 | 13.79B | 2.99B | 1.21B | 1.13B | 25.06 |
Bausch Health Companies Inc Stock (BHC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-08-02 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
| 2024-07-10 | 개시 | Raymond James | Mkt Perform |
| 2023-09-20 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 다운그레이드 | TD Cowen | Outperform → Market Perform |
| 2022-07-29 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-07-29 | 다운그레이드 | Truist | Buy → Hold |
| 2022-07-28 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-06-13 | 재개 | JP Morgan | Overweight |
| 2021-03-24 | 다운그레이드 | BofA Securities | Neutral → Underperform |
| 2021-02-17 | 업그레이드 | RBC Capital Mkts | Sector Perform → Outperform |
| 2021-01-22 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2020-09-17 | 업그레이드 | BofA Securities | Underperform → Neutral |
| 2020-08-24 | 재확인 | H.C. Wainwright | Buy |
| 2020-06-17 | 재확인 | H.C. Wainwright | Buy |
| 2020-04-24 | 개시 | Citigroup | Buy |
| 2020-04-02 | 다운그레이드 | Morgan Stanley | Overweight → Equal-Weight |
| 2020-01-29 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2020-01-22 | 업그레이드 | Wells Fargo | Underweight → Equal Weight |
| 2019-12-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2019-12-02 | 개시 | Goldman | Neutral |
| 2019-10-25 | 개시 | Cowen | Outperform |
| 2019-09-12 | 개시 | Guggenheim | Buy |
| 2019-08-15 | 업그레이드 | TD Securities | Hold → Buy |
| 2019-07-19 | 개시 | Wolfe Research | Outperform |
| 2019-06-11 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2019-03-20 | 개시 | SunTrust | Buy |
| 2019-01-02 | 업그레이드 | Piper Jaffray | Neutral → Overweight |
| 2018-11-05 | 업그레이드 | Morgan Stanley | Equal-Weight → Overweight |
| 2018-09-13 | 업그레이드 | Piper Jaffray | Underweight → Neutral |
모두보기
Bausch Health Companies Inc 주식(BHC)의 최신 뉴스
Bausch Health Companies Inc. Stock Analysis and ForecastTremendous financial leverage - PrintWeekIndia
Is Bausch Health Companies Inc. stock a good hedge against inflationExplosive wealth accumulation - jammulinksnews.com
Bausch Health adds two pharmaceutical industry veterans to board By Investing.com - Investing.com South Africa
Bausch Health Announces the Appointment of Two New Members to Its Board of Directors - The Joplin Globe
Bausch Health Expands Leadership: Ex-Viatris CEO and Bristol Myers Legal Chief Join Board in Strategic Move - Stock Titan
Is Bausch Health Companies Inc. a good long term investmentFast-track wealth growth - Autocar Professional
Hyperammonemia Market Trends 2025: Growth Drivers & Forecast | - openPR.com
What drives Bausch Health Companies Inc. stock pricePhenomenal wealth increase - jammulinksnews.com
IP Atty's FCA Suit Against Valeant Over Apriso Tossed Again - Law360
SANDRIDGE ENERGY, INC. ANNOUNCES APPOINTMENT OF BRETT ICAHN TO THE BOARD OF DIRECTORS - The Malaysian Reserve
What analysts say about Bausch Health Companies Inc. stockTremendous return on equity - jammulinksnews.com
Brett Icahn Takes Board Seat at SandRidge Energy: Major Strategic Move for Oil Producer - Stock Titan
Best Stock to Buy Right Now: Bausch Health vs Canopy Growth? - MSN
Bausch Health Faces Patent Drama And Policy Questions This Quarter - Finimize
Bausch Health's Xifaxan Patent Clarity, Policy Commentary in Focus for Q2, RBC Says - MarketScreener
In the Wake of Bausch Health Companies Inc.'s (NYSE:BHC) Latest US$196m Market Cap Drop, Institutional Owners May Be Forced to Take Severe Actions - 富途牛牛
In the wake of Bausch Health Companies Inc.'s (NYSE:BHC) latest US$196m market cap drop, institutional owners may be forced to take severe actions - simplywall.st
Amblyopia Market Growth Expected to See Next Level with Novartis - openPR.com
Bausch Health Companies (BHC) Canada Announces Expanded Availability of CABTREO Gel - Yahoo Finance
Icahn Enterprises shares rise 5.72% intraday after Bausch Health appoints new Chief Accounting Officer. - AInvest
Bausch Health's Strategic Leadership Shift: Steven Lee's Expertise Could Propel Valuation Growth Amid Transformation - AInvest
First-Ever Triple-Combination Acne Treatment CABTREO Expands Access Across Canadian Health Programs - Stock Titan
Bausch Health Names Steven Lee Chief Accounting Officer - MarketScreener
Bausch Health Appoints New Chief Accounting Officer - MarketScreener
Bausch Health Strengthens Finance Team: M&A Expert Steven Lee Takes Chief Accounting Officer Role - Stock Titan
Groundbreaking Triple-Combination Acne Treatment Expands Access Across Canadian Healthcare System - Stock Titan
Bausch Health's Gastroenterology Business, Salix Pharmaceuticals, Launches Fresh "I Wish I Knew" Campaign to Educate People About Xifaxan(R) (rifaximin) for Adults at Risk of Overt Hepatic Encephalopathy Recurrence - New Castle News
First FDA-Approved Drug Xifaxan Unveils Powerful Patient Stories in New Hepatic Encephalopathy Campaign - Stock Titan
SHAREHOLDER ALERT: Potential Recovery for Bausch Health Companies Inc. (BHC) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit - ACCESS Newswire
Bausch Health Companies Reaches Analyst Target Price - Nasdaq
August 22nd Options Now Available For Bausch Health Companies (BHC) - Nasdaq
Stocks In Play: Bausch Health Companies - Barchart.com
Bausch Health to Announce Second Quarter 2025 Results on July 30 - Corsicana Daily Sun
Bausch Health Companies Inc (BHC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.64%
0.68%
자본화:
|
볼륨(24시간):